What we found
On 2 June 2026 the Federal Trade Commission announced it had sued multilevel marketer Amare Global Holdings Inc. and three of its principals, alleging the company misrepresented to parents and other consumers that its dietary supplements for children and adults could treat or cure conditions such as depression, anxiety and ADHD. The FTC complaint names products including Kids Happy Juice, Kids Mood+ and the Happy Juice Product Pack, and alleges unsubstantiated claims that they lower or regulate cortisol, raise or normalise serotonin, dopamine and GABA, and cure, treat or mitigate depression, anxiety and ADHD. According to the FTC, the claims were amplified by a network of salespeople called "brand partners" who advertised on Instagram, TikTok, YouTube and Facebook, including assertions that the products were "scientifically backed" or clinically proven and would reduce the risk of suicide in children. The FTC also alleges deceptive earnings claims, saying the company told recruits that anyone could join and earn stated amounts such as $500 a month, or supplement or replace their income, even with no MLM sales experience and no large social media following. The FTC states that two of the individual defendants were already subject to earlier Commission orders prohibiting them from making false, misleading and unsubstantiated claims. A complaint is an allegation that a law has been broken; the harvested announcement records only that the case was filed in federal court, not any court ruling or finding against the defendants. Our harvested material does not say how many consumers bought these products, how much money buyers or recruits lost, or whether any refunds are available. Before buying any supplement pitched as treating a diagnosed condition such as depression, anxiety or ADHD, take the exact product name to a doctor or pharmacist and buy nothing until they have answered. LIVEFRAUD ALERTS is an independent consumer awareness desk with no affiliation to the Federal Trade Commission or to any company or person named here; the companies and products above are named only because an official source named them.
- The single source is a first-party FTC press release describing its own filed complaint, including specific product names, claim types and the Commission vote.
- All health and earnings statements are attributed allegations in a complaint, not adjudicated findings, so the underlying facts remain untested in court.
- Only one row was harvested, so there is no independent reporting to corroborate scale, consumer losses or company response.
- Reviewed by 3 models, 2 from independent houses.
THE RULE
Money spent on supplements sold with unproven medical promises for children, plus recruitment pitches promising stated monthly earnings.
What we don’t know
- Whether a court will agree with any of the FTC's allegations.
- How many parents or recruits were affected, and the total money involved.
- Whether refunds, redress or product recalls will follow.
- What the defendants say in response, and whether the products remain on sale.
The bench — who voted
3 INDEPENDENT AI MODELS REVIEWED THIS. 2 OF 3 — ONE MODEL DISSENTED. READ WHY.
The card names a count. Here are the seats behind it, with what each one said.
ANTHROPICclaude-opus-5 · HIGH
Only one evidence row is provided, and it is a one-sentence summary. Almost every specific in the finding is absent from it: the 2 June 2026 announcement date, the product names (Kids Happy Juice, Kids Mood+, Happy Juice Product Pack), the biochemical claims (cortisol, serotonin, dopamine, GABA), the named conditions (depression, anxiety, ADHD), the platforms (Instagram, TikTok, YouTube, Facebook), the 'scientifically backed' and suicide-risk assertions, and the '$500 a month' figure. The row supports only the fact of a suit over unsubstantiated health claims for children's and adults' supplements and deceptive earnings claims to 'brand partner' recruits.
DISSENT, PRESERVEDThe framing discipline in the draft is good and should be preserved even if the specifics are cut: it says plainly that a complaint is an allegation, notes the absence of any ruling, lists what the harvested material does not establish, and disclaims affiliation with the FTC. The problem is sourcing depth, not tone.
DISSENT, PRESERVEDOn danger I grade high and would defend it. Supplements pitched to parents as treating a child's diagnosed depression, anxiety or ADHD invite substitution for real clinical care, and an MLM recruitment layer means the people making the health claims are financially motivated and often untrained. That combination can cause harm well before any court rules on the FTC's allegations.
DISSENT, PRESERVEDIf the specifics cannot be sourced to the complaint itself before publication, the alert should run as a short filing notice naming only the company, the fact of the suit and the two categories of alleged misrepresentation, plus the doctor-or-pharmacist advice, which stands on its own.
GROQopenai/gpt-oss-120b · MODERATE
Finding adds product names and specific claim details (cortisol, serotonin, suicide risk) not present in the single evidence row, which only states FTC alleges false health and earnings claims.
OPENROUTERopenrouter/free · MODERATE
Raised no objection; read the evidence as holds.
Reviewed by 3 independent models: 1 found it carried by the evidence, 2 did not.
▼ Protocol & challenge record
Objection (medium): Product-to-allegation mismatch. The FTC's bullet list of unsubstantiated claims names "Happy Juice, Kids Mood+ and Kids Happy Juice". The draft writes "Kids Happy Juice, Kids Mood+ and the Happy Juice Product Pack" and then attaches the cortisol/serotonin/dopamine/GABA and cure-treat-mitigate allegations to that trio. "Happy Juice Product Pack" appears in the source only in the sentence listing what Amare sells, not in the substantiation bullets. Naming a specific commercial SKU as the subject of an unsubstantiated-claims allegation when the source did not is exactly the kind of one-word drift that becomes a defamation/correction problem. Use the FTC's own three names, or say "products including Happy Juice, Kids Mood+ and Kids Happy Juice" and mention the Happy Juice Product Pack separately as a product Amare sells.
Resolved: Rewrite the sentence to track the FTC bullets exactly: "...alleges unsubstantiated claims that products including Happy Juice, Kids Mood+ and Kids Happy Juice lower or regulate cortisol..." and, if the Happy Juice Product Pack is retained, place it only in a clause describing what Amare sells.
Objection (medium): The draft shifts the advertising conduct off the company and onto the sales network. Source: "The defendants and their brand partners advertise Amare's products on social media, including on Instagram, TikTok, YouTube and Facebook." Draft: "the claims were amplified by a network of salespeople called 'brand partners' who advertised on Instagram, TikTok, YouTube and Facebook." That reads as though only the downline advertised. It understates the FTC's allegation against the corporate and individual defendants and, for a reader, wrongly implies the risk is rogue distributors rather than the company itself. Add "the defendants and their brand partners".
Resolved: Change "the claims were amplified by a network of salespeople" to "the defendants and their network of salespeople, called 'brand partners', advertised on Instagram, TikTok, YouTube and Facebook, and the brand partners amplified the claims" — restoring the company-level conduct the source alleges.
Objection (medium): Risk line understates the harm the source actually emphasises. The FTC's Bureau Director is quoted calling the claims "not only deceptive but dangerous" because parents of children with serious conditions "need proven treatments". The draft's risk_line is purely financial ("Money spent on supplements..."). The distinctive consumer harm here is a child with depression, anxiety or ADHD being given a juice powder instead of, or in place of, evidence-based care — including the alleged suicide-risk-reduction claim the draft itself reports. A money-only risk line is an under-claim on the single most serious element in the record.
Not resolved — preserved on the record.
Objection (medium): Advice omits the safety step that matters most. "Take the exact product name to a doctor or pharmacist and buy nothing until they have answered" is fine for a prospective buyer, but the population at risk per the source is parents who may already be substituting these products for treatment. The advice should also say: do not stop or reduce a child's prescribed treatment on the strength of a supplement marketing claim; talk to the prescriber first. This is generic safety advice and does not need a source row.
Resolved: Append to the advice sentence: "and do not stop or change a child's prescribed treatment because of a supplement marketing claim — speak to the prescriber first." No new source row required; this is generic safety guidance.
Objection (low): Date-currency / staleness check is absent. Everything rests on one press release dated 2026-06-02 describing a same-day filing in the Central District of California. FTC MLM/health-claim filings frequently move fast (TRO, asset freeze, stipulated order, receiver) and are often accompanied within days by a company statement. Nothing in the draft records when the check was run or that no later docket entry or company response was found. If this publishes weeks or months after 2 June 2026, "the case was filed" may already be superseded. Add an as-of date and an explicit "no later development found as of X" line, or downgrade currency.
Not resolved — preserved on the record.
Objection (medium): directive_options is contaminated with artefacts that should never have been generated. "Send this to any christopher you know" is plainly derived from Christopher Mufarrige (FTC Bureau Director) and/or Christopher Erickson (FTC staff attorney) — i.e. the pipeline mined a first name out of an official's byline and turned it into a targeting instruction. "Send this to any shareholder you know" and "Forward this to the shareholders in your life" are derived from David Chung being described as "majority shareholder". None of these groups is described anywhere as at risk. share_directive was correctly set to null, but the option set itself is evidence of a targeting-generation defect that will produce a bad output on some other story where the null guard does not fire. This should be logged as a pipeline bug, not just dropped silently.
Not resolved — preserved on the record.
Objection (low): callout_options includes "ATTENTION: PARENTS OF KIDS WITH ADHD" and "ATTENTION: EVERYONE". The first implies a specific diagnosed cohort was targeted; the source says brand partners took advantage of "parents looking for products to help their children, who suffer from serious conditions like depression and anxiety" — ADHD appears as a claimed indication, not as a described victim group. The second is meaningless. The selected callout is fine; the option pool is not, for the same reason as OBJ-6.
Not resolved — preserved on the record.
Objection (low): Watch icon "card" is unsupported. The harvested row says nothing about payment method, subscriptions, autoship or card charges. "video" (social video ads) and "person" (recruitment/downline) are defensible; "card" is inferred from the generic shape of an MLM story, not from this record.
Not resolved — preserved on the record.
Objection (low): Confidence is labelled "high" while two of the three confidence_reasons are reasons for caution (untested allegations, single row, no corroboration, no defendant response). The label is defensible only because the claim object is "an FTC complaint alleges X" rather than "X happened". Say so explicitly — "high confidence that the FTC filed and alleged this; no confidence on the truth of the underlying conduct" — otherwise the label reads as endorsement of the allegations.
Resolved: Keep confidence high but restate the confidence object in one clause: high that the filing and its contents are as described (first-party agency announcement); nil on the truth of the allegations, which are untested.
Objection (low): Omissions that cost the reader useful, sourced specificity: the three individuals are named in the source (Shawn Talbott, former chief science officer; Patrick Hintze, founding brand partner; David Chung, current CEO and majority shareholder), as is the 2-0 Commission vote and the Central District of California venue. The draft names the company and the products but withholds the individuals while asserting in its disclaimer that "the companies and products above are named only because an official source named them." That is internally consistent but arguably arbitrary: "two of the individual defendants were already subject to earlier Commission orders" is a serious statement that is harder for a reader to verify when the names are withheld. Either name them (the source does) or drop the prior-orders sentence to a general note.
Not resolved — preserved on the record.
Objection (low): Tense drift on the prior orders. Source: Talbott and Hintze "are subject to previous orders". Draft: "were already subject to earlier Commission orders". The past tense can be read as "no longer subject", which inverts the point — the FTC's point is that the orders are live and were allegedly violated.
Resolved: Change "were already subject" to "are subject to earlier FTC orders that prohibit them from making false, misleading and unsubstantiated claims."
Preserved dissent
ON THE RECORDI do not accept the risk line as written. The FTC's own quoted language is that the conduct was "not only deceptive but dangerous" because parents of children with serious conditions "need proven treatments", and the draft itself reports an alleged claim that the product reduces suicide risk in children. Reducing that to "money spent on supplements" is an under-claim on the most serious fact in the record. A consumer desk that leads with the wallet when the source leads with the child has mis-weighted the harm.
ON THE RECORDThe advice paragraph is incomplete in a way I consider a safety defect, not a style preference. The realistic reader is a parent who has already bought this and may be tapering or withholding prescribed care. Telling them only "ask before you buy" misses that reader entirely.
ON THE RECORDdirective_options containing "Send this to any christopher you know" is not a harmless discarded candidate. It shows the targeting generator will lift a proper noun out of an FTC official's attribution line and convert it into an instruction to forward an alert to people with that name. The null guard caught it here. I do not believe it will catch it every time, and I want this recorded as an open pipeline defect rather than a resolved per-story drop.
ON THE RECORDAttributing the social-media advertising solely to "brand partners" when the source says "the defendants and their brand partners" is a small edit with a directional effect: it makes the corporate defendants look like victims of an unruly downline. I would not let that stand even as a compression.
The sources
Official sourceFTC Sues to Stop Amare Global Holdings from Misrepresenting the Health Benefits of Its Dietary Supplements for Children and Adults2026-06-02
The FTC sued Amare Global Holdings Inc. and three principals over allegedly false and unsubstantiated health claims for children's and adults' supplements, and over deceptive earnings claims made to "brand partner" recruits.
Authority: official. Retrieved 2026-08-20.
Limitation: This is the agency's own announcement of allegations it filed; it contains no court decision, no consumer loss figures and no response from the defendants.
Open the original source →Other checks
Published under standing founder pass (A9) — every claim source-mapped by the machine.
▼ What the machine checked
- ✓ Not a community submission.
- ✗ Draws on an FTC enforcement release, which names a defendant: "FTC Sues to Stop Amare Global Holdings from Misrepresenting the Health Benefits ".
- ✓ All 5 material sentence(s) map to FTC.
- ✗ anthropic returned "overstated"; groq returned "overstated" — published on the receipt, not blocking (A9 amendment).
- ✓ No audience band is set.
No human affirmed these. They were verified by the classifier described in Amendment A9, on 2026-08-20.
Something wrong here? Tell us and we'll correct it — corrections are published, not quietly edited.
Phishy? Send it → sharelivefraud.com/squire-it
Not affiliated with any government agency, credit bureau, bank, platform, or law-enforcement agency. Informational only — not legal or financial advice.
Naming a source is not an endorsement, and being named here is not an accusation against any company.
Powered by SquireIt™
Verify this receipt at squireit.com